TEWKSBURY, MA / ACCESSWIRE / April 25, 2024 / Cambridge Isotope Laboratories, Inc. (CIL) has acquired an additional 14.8 ...

According to a recent report by Market.us, the Global Drug of Abuse Testing Market size is expected to be worth around USD 11 ...

Term Care Market size is expected to be worth around USD 2,168.1 Billion by 2032 from USD 1,180.0 Billion in 2023, growing at ...

MAULDIN, SC / ACCESSWIRE / April 25, 2024 / Xcelerate, Inc. (OTCQB:XCRT) today announced that ESN Group, Inc., a subsidiary of Xcelerate, has gone live with the first of its Ceramedx® product ...

Across Africa and Low & Middle Income Countries (LMIC) U.S. Patent No. 11,967,402 System and Method for Offline Data Collection and Synchronization for Managing a ...

Moleculin CEO, Walter Klemp highlights Annamycin differentiation in the current AML treatment landscape and potential opportunity FRENCHTOWN, NJ / ACCESSWIRE / April 25, 2024 / JTC Team ("JTC"), a ...

TORONTO, ON / ACCESSWIRE / April 25, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu"), ...

According to Market.Us, the Global Dermatoscope Market was valued at USD 967.4 Million in 2022. It is projected to witness substantial growth, reaching an estimated value of USD 3,076.7 million by ...

Financing1.6 million euros for Hanf Farm: Federal Ministry for Economic Affairs and Climate Protection funds bio-economy project (news with additional features)25.04.2024 / 12:33 CET/CESTThe issuer is ...

According to Market.Us, the Global Aesthetic Lasers Market was valued at USD 1,137.7 Million in 2022. It is projected to achieve substantial growth, reaching USD 5085.2 Million by 2032, with the ...

The Global Peracetic Acid Market was valued at USD 905 million in 2022 and is projected to reach USD 1,899 million by 2032. Between 2023 and 2032, the market is estimated to register the highest ...

SALT LAKE CITY, UT / ACCESSWIRE / April 25, 2024 / In the first calendar quarter (1Q) of 2024, Utah Medical Products, Inc. (NASDAQ:UTMD) attained financial results consistent with its previously ...